Literature DB >> 29273695

Cardiac Displacement During 13N-Ammonia Myocardial Perfusion PET/CT: Comparison Between Adenosine- and Regadenoson-Induced Stress.

Elise J Vleeming1,2, Sergiy V Lazarenko3,2, Friso M van der Zant3,2, Xiao-Bo Pan4, Jerome M Declerck4, Maurits Wondergem3,2, Remco J J Knol3,2.   

Abstract

This study investigated differences in cardiac displacement during adenosine stress versus regadenoson stress in 13N-ammonia (13NH3) MP PET/CT scans.
Methods: In total, 61 myocardial perfusion PET/CT scans were acquired using either adenosine (n = 30) or regadenoson (n = 31) as a stressor. For both groups, cardiac displacement during rest and stress was measured 3-dimensionally, relative to either a fixed reference frame or the previous frame, in each 1-min frame of a list-mode PET acquisition of 25 min. All stress scans were additionally evaluated for the presence of motion artifacts. Also, the tolerability of the agents and the occurrence of side effects were compared between groups.
Results: Significantly larger cardiac displacement during stress was detected in the adenosine group than in the regadenoson group, reflected by both maximal cardiac displacement (P = 0.022) and mean cardiac displacement (P = 0.001). The duration of the movement was typically shorter in the regadenoson group. Frames with cardiac displacement of at least 5 mm were observed nearly twice as frequently when adenosine was used instead of regadenoson.
Conclusion: The displacement during regadenoson stress is of lower amplitude and shorter duration than that during adenosine stress and may therefore contribute to a lower incidence of motion artifacts on PET/CT scans.
© 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  adenosine; ammonia; motion artifacts; myocardial perfusion PET/CT; pharmacologic stress; regadenoson

Mesh:

Substances:

Year:  2017        PMID: 29273695     DOI: 10.2967/jnmt.117.199463

Source DB:  PubMed          Journal:  J Nucl Med Technol        ISSN: 0091-4916


  5 in total

1.  EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Authors:  Roberto Sciagrà; Mark Lubberink; Fabien Hyafil; Antti Saraste; Riemer H J A Slart; Denis Agostini; Carmela Nappi; Panagiotis Georgoulias; Jan Bucerius; Christoph Rischpler; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-02       Impact factor: 9.236

2.  Myocardial blood flow: Is motion correction necessary?

Authors:  Martin Lyngby Lassen; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2019-09-20       Impact factor: 5.952

3.  Dynamic cardiac PET motion correction using 3D normalized gradient fields in patients and phantom simulations.

Authors:  Jonathon A Nye; Marina Piccinelli; Doyeon Hwang; Charles David Cooke; Jin Chul Paeng; Joo Myung Lee; Sang-Geon Cho; Russell Folks; Hee-Seung Bom; Bon-Kwon Koo; Ernest V Garcia
Journal:  Med Phys       Date:  2021-07-20       Impact factor: 4.506

4.  Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease.

Authors:  Mark Lubberink; Juhani Knuuti; Tanja Kero; Antti Saraste; Bo Lagerqvist; Jens Sörensen; Essi Pikkarainen
Journal:  J Nucl Cardiol       Date:  2021-08-12       Impact factor: 5.952

5.  Influence of patient motion on quantitative accuracy in cardiac 15O-water positron emission tomography.

Authors:  Jonny Nordström; Hendrik J Harms; Tanja Kero; Jens Sörensen; Mark Lubberink
Journal:  J Nucl Cardiol       Date:  2021-03-02       Impact factor: 3.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.